Moreover, miR-182, which was commonly up-regulated in early-stage Lebanese and US patients and in Cx43-KO-S1 compared to S1 cells, was up-regulated in various human breast cancer subtypes and acted as an oncogene68. The gene discussed is GJA1; the disease is breast carcinoma.